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Abstract
Mosquito-borne diseases are major health problems worldwide. Serological responses to mosquito saliva proteins may be
useful in estimating individual exposure to bites from mosquitoes transmitting these diseases. However, the relationships
between the levels of these IgG responses and mosquito density as well as IgG response specificity at the genus and/or
species level need to be clarified prior to develop new immunological markers to assess human/vector contact. To this end,
a kinetic study of antibody levels against several mosquito salivary gland extracts from southeastern French individuals
living in three areas with distinct ecological environments and, by implication, distinct Aedes caspius mosquito densities
were compared using ELISA. A positive association was observed between the average levels of IgG responses against Ae.
caspius salivary gland extracts and spatial Ae. caspius densities. Additionally, the average level of IgG responses increased
significantly during the peak exposure to Ae. caspius at each site and returned to baseline four months later, suggesting
short-lived IgG responses. The species-specificity of IgG antibody responses was determined by testing antibody responses
to salivary gland extracts from Cx. pipiens, a mosquito that is present at these three sites at different density levels, and from
two other Aedes species not present in the study area (Ae. aegypti and Ae. albopictus). The IgG responses observed against
these mosquito salivary gland extracts contrasted with those observed against Ae. caspius salivary gland extracts,
supporting the existence of species-specific serological responses. By considering different populations and densities of
mosquitoes linked to environmental factors, this study shows, for the first time, that specific IgG antibody responses against
Ae. caspius salivary gland extracts may be related to the seasonal and geographical variations in Ae. caspius density.
Characterisation of such immunological-markers may allow the evaluation of the effectiveness of vector-control strategies
or estimation of the risk of vector-borne disease transmission.
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Introduction
Mosquito-borne diseases are a major health problem world-
wide, and cause important morbidity and mortality in tropical
areas [1,2]. To a lesser extend, the European population is also
exposed to a variety of mosquito-borne pathogens. Outbreaks of
mosquito-borne diseases with significant human health implica-
tions occurred on a mass scale in Europe in the last century. These
outbreaks included the following: Dengue virus in Greece in 1928
[3], West Nile virus in Camargue in 1962 [4] and in Romania in
1996 [5], Sindbis virus in Finland in 2002 [6] and more recently,
Chikungunya virus in Italy [7].
Numerous indexes can provide a comprehensive understanding
of the potential for mosquito-borne disease transmission and the
dynamics of these diseases in human populations, such as the
vectorial capacity, the basic reproductive rate (R0) and the
entomological inoculation rate (EIR) [8,9]. These indicators of
disease transmission levels can also quantify the impact of vector-
control strategies [9]. These indexes mainly depend on entomo-
logical parameters that can be measured in the field, including the
human-biting rate (HBR) (average number of bites per individual
per day received from a mosquito species) [10]. This parameter is
currently estimated by entomological methods, such as human
landing catches, or other strategies based on attractant traps (e.g.,
light traps, carbon-dioxide traps, odour-baited traps) [11]. These
entomological methods have proven efficacy for monitoring the
density of mosquitoes relative to the density of the human
population [12–14] but the HBR has been shown to vary within
small geographic areas [15,16], meaning that the results of local
catches cannot be extrapolated to larger areas. These methods are
not adapted to consider differences found within a population,
which include differential attractiveness to mosquitoes [17] or
other environmental and socioeconomic factors that could induce
important variations in individual exposure to vector bites.
Moreover, entomological methods can be labour intensive,
expensive and difficult to implement when mosquito numbers
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deliberate exposure of human volunteers to vectors has raised
some ethical issues related to human landing catches, which
remains the most reliable method to estimate host/vector contacts
[11].
The use of immunologically based techniques to estimate
individual exposure to arthropod vector bites, such as those from
mosquitoes, ticks, sand flies and Glossina, has been described in
several studies [18–22]. The saliva of hematophagous arthropods
contains a complex mixture of biologically active proteins. These
proteins may modify hemostatic responses and induce both
cellular immunity and the production of specific antibodies
[23,24]. As described previously, mosquito salivary gland extracts
can induce an IgG antibody response in individuals living in
endemic areas [25–27] and in travellers transiently exposed to
vectors in tropical areas [28], suggesting that salivary proteins can
potentially be used as immunological markers to evaluate
individual exposure to mosquito bites.
Mosquito densities and species diversity can be influenced by
the surrounding landscape, even in restricted areas [29,30]. The
Mediterranean coast of southern France presents areas with
distinct demographic and ecological conditions, ranging from
large wetland areas in the Rhone River delta (Camargue) to highly
urbanised environments (city of Marseille). These contrasting
landscapes mirror the density and geographical spread of some
mosquito species, notably Aedes caspius.
Ae. caspius is a Paleartic species that has demonstrated the ability
to transmit the Rift Valley fever virus and the Chikungunya virus
in the laboratory [31,32]. This mosquito species was also suspected
to be involved in the 1993 Rift Valley fever outbreak in Egypt
[33]. Despite its low vector competence for these viruses, Ae. caspius
should be considered a potential vector in wetland areas due to its
high anthropophily and its abundance. Aedes caspius is well adapted
to swampy environments: it tolerates varying levels of salinity in
larval breeding sites, and its larval development is linked to the
alternating dry and wet seasons in areas where its eggs are laid
[34]. After abundant rainfalls events, a massive, synchronous adult
population emerges and becomes a nuisance [35]. In Camargue,
Ae. caspius is active from March to November [36,37]. Ae. aegypti
and Ae. albopictus mosquitoes, both vectors of arboviruses (e.g.,
yellow fever, dengue or chikungunya viruses), were not endemic in
the study area at the time of the present work [38].
To assess whether exposure to different densities and/or species
of mosquitoes throughout the year could influence the antibody
response against mosquito salivary gland extracts, we tested the
IgG response to Ae. caspius salivary gland extracts of individuals
living in three southern French areas (Camargue, Fos-sur-mer and
Marseille) with distinct ecological environments at three time
points (February 2007, September 2007 and January 2008). We
concomitantly evaluated the IgG responses to salivary gland
extracts from Culex pipiens, Aedes albopictus and Aedes aegypti as
controls. The temporal and spatial evolution of IgG responses
according to mosquito species will be discussed.
Results
Kinetics of IgG antibody responses against Ae. caspius
salivary gland extracts (AecSGE) from individuals living in
distinct ecological environments
First, we determined whether mosquito density, linked to the
ecological environment and season, could influence the IgG
responses against mosquito salivary gland extracts. Thus, the IgG
responses against AecSGE were assessed in individuals living in
Camargue, Fos-sur-mer or Marseille (Figure 1) at three time
points: February 2007 (T1) and January 2008 (T3), which
corresponded to periods outside of the Ae. caspius exposure peak,
and September 2007 (T2), which corresponded to the Ae. caspius
exposure peak period [36]. Independent of the sampling time (i.e.,
T1, T2 or T3), the IgG antibody responses against AecSGE were
significantly different among the sites (Kruskal-Wallis test,
p,0.0001, Table S1). Additionally, independent of the site, the
IgG response against AecSGE increased significantly from T1 to
T2 (Figure 2A, Wilcoxon matched pairs test, p,0.0001, p,0.0018
and p,0.0001 for the Camargue, Fos-sur-mer and Marseille sites,
respectively, Table S1) and decreased significantly from T2 to T3
(Wilcoxon matched pairs test, p,0.0001 for the three sites). These
variations gradually decreased in individuals living at the
Camargue site (i.e., the mean change in DT2-T1OD was +0.26,
with a 95% confident interval (95% CI) from +0.14 to 0.38)
compared to those living in the city of Marseille (i.e., +0.05 [0.01 to
0.09]), with intermediate variation observed for those living in Fos-
sur-mer (i.e., +0.13 [0.07 to 0.18]). The mean changes in DT2-
T1OD between the Camargue and Fos-sur-mer as well as the
Camargue and Marseille sites were significantly different
(p=0.019 and p,0.0001, respectively, Mann-Whitney test). No
significant differences (Mann-Whitney test, ns) were observed
when comparing the mean change in DT2-T1OD between the
Fos-sur-mer and Marseille sites. In contrast, outside of the period
of peak exposure to mosquito bites (i.e., T1 and T3) at the three
sites, the antibody response against AecSGE returned to the
background level at each site (Camargue, +0.04 [20.06 to 0.14];
Fos-sur-mer, +0.09 [20.13 to 20.04]; Marseille, +0.01 [20.02 to
0.04]). Variations in the IgG antibody responses detected between
T3 and T1 were considered not to differ (mean DT3-T1OD
,0.1). The cut-off value for seropositivity (mean aOD 63
standard deviation) was defined as 1.03 based on the IgG
reactivity of sera from individuals living in Marseille who were
not exposed to Ae. caspius. Individuals showing aOD values above
this cut-off level were classified seropositive. Seroprevalence
significantly increased among individuals living at the Camargue
study site from the T1 time point to the end of the exposure peak
(T2), with values increasing from 29% to 54% (chi-squared test,
p,0.0249, Figure 2B). In addition, seroprevalence significantly
declined after the exposure peak and returned to the baseline level
(T3=29%, chi-squared test, p,0.0249). Although an increase in
seroprevalence was observed from T1 to T2 and a decrease was
observed from T2 to T3 for individuals living at the Fos-sur-mer
study site, these variations were not significant (chi-squared test,
Figure 2B). No significant change in seroprevalence was observed
between T1 and T3 at the Fos-sur-mer and Camargue sites.
Additionally, no significant differences were observed when
comparing seroprevalence between the two study sites indepen-
dently of the sampling time (chi-squared test).
Kinetics of IgG antibody responses to Cx. pipiens salivary
gland extracts (CxpSGE) in individuals living in distinct
ecological environments
The IgG responses to CxpSGE were assessed using the same sera
as that used for the AecSGE assay. High inter-individual
heterogeneity in the antibody responses was observed at all time
points and for all sites (Figure 3). Independent of the sampling time
(i.e., T1, T2 or T3), no significant difference was observed in the
IgG antibody responses to CxpSGE between the sites (Kruskal-
Wallis test, Table S1). With respect to the kinetics, despite
statistically significant variation being detected in the IgG antibody
response to CxpSGE between the T2 and T3 time points for the
Camargue and Fos-sur-mer sites (Wilcoxon matched pairs test,
p,0.0001 and p=0.0028 for the Camargue and Fos-sur-mer sites,
Mosquito Saliva: Immunological Markers of Exposure
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antibody variations for the Camargue and Fos-sur-mer sites were
considered not to differ (below than 0.1 DOD), indicating global
stability of IgG responses to CxpSGE throughout the year.
Conversely, in the city of Marseille, the variations in the IgG
responses observed from T1 to T2 and T2 to T3 were significant
(Wilcoxon matched pairs test, p=0.016/74 and p,0.0001 for
DT2-T1OD and DT3-T2OD, respectively) and relevant (DT2-
T1OD +0.1 [0.01 to 0.19]; DT3-T2OD 20.15 [20.21 to 0.08]).
Kinetics of antibody responses to Ae. albopictus
(AealSGE) and Ae. aegypti salivary gland extracts
(AeaeSGE) in individuals living in distinct ecological
environments
To estimate the specificity of the IgG response to AecSGE, the
same sera were assessed for IgGs against salivary gland extracts of
two mosquitoes from the Aedes genus (i.e., Ae. albopictus and Ae.
aegypti) that were not endemic in the study area until 2008
(Figure 4) [38]. Independent of the sampling time (i.e., T1, T2 or
T3), no significant difference was observed when the IgG antibody
responses to AealSGE or AeaeSGE were compared between sites
(Kruskal-Wallis test, Table S1). With regard to the kinetics
analysis, despite statistically significant variations being detected in
the IgG antibody response to AealSGE or AeaeSGE between some of
the time points at the three sites, these variations were below 0.1
DOD and were considered to not differ.
Correlation of the IgG response between mosquito
species
To estimate the level of cross-reactivity of the IgG response to
the salivary gland extracts between two mosquito species at T2
(September 2007) at the three sites, a Spearman’s rank correlation
coefficient (rho) test was used, and the corresponding p-values were
determined (Table 1). Significant positive correlation coefficients
(rho.0.42; p,0.0083) were obtained when the mosquitoes of the
Aedes genus were compared at the three sites, mainly for IgG
responses against non-prevalent mosquitoes (i.e., albopictus and
aegypti). Conversely, no significant correlation was observed
between the IgG responses against CxpSGE and those against the
three other Aedes species at the three sites, except for the Fos-sur-
mer site, where a significant positive correlation coefficient
(rho=0.43; p=0.0079) was obtained when the IgG responses
against CxpSGE and AecSGE were compared (Table 1).
Discussion
Numerous studies have reported that mosquitoes’ salivary
components can induce an antibody response in humans under
natural conditions [21,26,27,39]. Here, we analysed human
antibody responses against AecSGE according to spatial (environ-
ment) and temporal (seasons) variations in the level of Ae. caspius
mosquito exposure. The specificity of the IgG response was also
estimated at the genus and species levels.
The Mediterranean coast of southern France includes areas
with distinct demographic and ecological conditions that greatly
influence the dispersion and composition of the mosquito fauna.
Thus, three sites were selected in this area on the basis of
environmental patterns influencing Ae. caspius density: the
Camargue area, the town of Fos-sur-mer and the city of Marseille.
In the Camargue wetlands, Ae. caspius is well adapted to the rural
and swampy environment where it encounters favourable climatic
and biotope conditions [34,35]. The city of Marseille presents an
urban habitat that is more suitable for Cx. pipiens mosquitoes than
rural mosquitoes, such as Ae. caspius [35,40]. Fos-sur-mer, a mid-
sized town located between the Camargue area and Marseille, has
an intermediary environment and is also exposed to Ae. caspius
mosquitoes. To confirm the geographic distribution and the
Figure 1. Location of the study sites. The city of Marseille and the town of Fos-sur-mer are indicated by circles, and the Camargue area is cross-
hatched.
doi:10.1371/journal.pone.0029107.g001
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of mosquitoes was conducted in July 2007 using carbon dioxide
dry ice traps. The collected specimens indicated a decreasing
mosquito density gradient from Camargue to Marseille. Cx. pipiens
and Ae. caspius were the most abundant mosquitoes at Camargue
(31% and 29%, respectively), as previously described [36,41]. Ae.
caspius mosquitoes were captured at the Fos-sur-mer site (21%), but
none were found in Marseille (Table S2). Thus, Camargue, Fos-
sur-mer and Marseille were considered sites with high, medium
and very low levels of exposure to Ae. caspius bites, respectively.
In the present study, we showed that the IgG antibody responses
to AecSGE evolved in accordance with the Ae. caspius density, which
Figure 2. Spatial and seasonal variations of IgG responses to Ae. caspius salivary gland protein extracts. (A) IgG serum levels against Ae.
caspius salivary gland protein extracts. Scatter plots of IgG antibody responses against Ae. caspius salivary gland extracts in individuals from Marseille
(squares), Fos-sur-mer (circles) and Camargue (triangles) at three times February 07 (T1), September 07 (T2) and January 08 (T3), are presented with
the sampling time indicated in white, grey and black symbols, respectively. Antibody responses are represented by aOD: the mean OD value of wells
with antigen minus the mean OD value of wells without antigen. Each point shows the aOD value for a single individual. Horizontal bars show
medians. Differences between the two time points at a single site were tested using the Wilcoxon signed-rank test. p-values are indicated. (B)
Seasonal variation of seroprevalence against Ae. caspius salivary gland protein extracts at the three study sites. Seroprevalence against Ae. caspius
salivary gland extracts in individuals from Fos-sur-mer and Camargue at three times February 07 (T1, white bars), September 07 (T2, light grey bars)
and January 08 (T3, dark grey bars) are represented. Whiskers indicate the 95% confidence interval. The p values were determined by the chi-squared
test.
doi:10.1371/journal.pone.0029107.g002
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environment. The variations in the IgG antibody levels against
AecSGE between the peak exposure at T2 and the T1 baseline level
were approximately 2- and 4-fold higher in Camargue than in Fos-
sur-mer and Marseille, respectively. This positive relationship
between anti-salivary protein IgG levels and the seasonal variation
of human exposure to mosquito bites has previously been reported
[20,25,42,43]. Moreover, the average IgG response level against
AecSGE observed at T3 returned to T1 baseline levels only four
months after the exposure peak (T2), suggesting a short-lived IgG
response. A decrease in the IgG response against salivary gland
extracts after a period of non-exposure has been described for
outdoor workers exposed to ticks [44] and for travellers transiently
exposed to An. gambiae and Ae. aegypti mosquitoes [28]. The
transient anti-saliva IgG response and its relationship with
mosquito density may be useful for assessing mosquito exposure
and could thus, provide new immunological tools to evaluate anti-
vector strategies or to monitor vector populations [23]. Recently,
Drame and colleagues have confirmed the potential of An. gambiae
saliva for use as an immunological exposure marker to assess the
risk of malaria transmission and the efficiency of antivectorial
strategies in a malaria-endemic area [45].
It is worth pointing out that baseline IgG levels against AecSGE
were significantly and pertinently higher at Camargue and Fos-
sur-mer than at Marseille. Repeated seasonal exposure to Ae.
caspius seemed to favour maintaining a high baseline IgG level
throughout the year. To test this hypothesis, a comparison of the
kinetics of the IgG response against AecSGE, collected outside the
Ae. caspius exposure peak (cold season) between individuals who
had lived for a long period (i.e., at least 5 years) in Camargue and
newcomers could be performed. Further studies may also analyse
the kinetics of the antibody response in children born in
Camargue. Collectively, these data suggest that to determine the
prevalence of seroreactivity against AecSGE, several parameters
should be considered, including mosquito density and the
environment, historical mosquito exposure (time spent in a
particular area) and individual behaviour (e.g., outdoor/indoor
activities, use of mosquito nets or repellents).
To evaluate the specificity of this IgG antibody response, the
same sera were first tested against CxpSGE. The mosquito
collection performed in July 2007 indicated that Cx. pipiens was
present at all sites, with decreasing densities observed from
Camargue to Marseille. In contrast to the IgG response observed
to AecSGE, the IgG levels against CxpSGE were considered not to
differ spatially and temporally, with the exception of the levels
from Marseille. Individuals from Marseille presented a significant
and pertinent increase in the IgG levels against CxpSGE after the
peak of exposure. These results indicated that unlike the responses
against Ae. caspius, the IgG responses against CxpSGE appeared to
not be associated with the decreasing density of Cx. pipiens from
Figure 3. IgG serum levels anti-Cx. pipiens salivary gland protein extracts. Scatter plots of IgG antibody responses against Cx. pipiens salivary
gland extracts in individuals from Marseille (squares), Fos-sur-mer (circles) and Camargue (triangles) at three times, February 07 (T1), September0 7
(T2) and January 08 (T3), are represented in white, grey and black symbols, respectively. Antibody responses are represented by aOD: the mean OD
value of wells with antigen minus the mean OD value of wells without antigen. Each point shows the aOD value for a single individual. Horizontal
bars show medians. Differences between two sampling times at a single site were tested using the Wilcoxon signed-rank test. p-values are indicated.
doi:10.1371/journal.pone.0029107.g003
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distinct Cx. pipiens behaviour that could occur between sites. The
temperate species Culex pipiens Linne ´ can effectively be divided into
two different biological forms: Culex pipiens pipiens (Cx. p. pipiens) and
Culex pipiens molestus (Cx. p. molestus) [46,47]. These two subspecies
are relatively morphologically similar but exhibit different
physiological and behavioural traits [48,49]. In contrast to the
rural Cx. p. pipiens, the urban Cx. p. molestus is anthropophilic [49],
breeds in underground urban habitats, is able to lay its first batch
of eggs without a blood meal, does not hibernate and can mate in
confined spaces [41,47]. In Camargue, Culex pipiens L. mosquitoes
were found at a high density in bird-baited traps compared to
horse or human baited-traps, suggesting that the non-anthropo-
philic form of Culex pipiens L. dominates in this rural area [36,41].
This species is a moderately efficient laboratory West Nile virus
vector, but in southern France, it is considered to be a main vector
Figure 4. IgG serum levels anti-Ae. aegypti and anti-Ae. albopictus salivary gland protein extracts. Scatter plots of IgG antibody responses
against the salivary gland extracts of Ae. aegypti (A) and Ae. albopictus (B) in individuals from Marseille (squares), Fos-sur-mer (circles) and Camargue
(triangles) at three time points February 07 (T1), September 07 (T2) and January 08 (T3), are represented in white, grey and black symbols,
respectively. Antibody responses are represented by aOD: the mean OD value of wells with antigen minus the OD value of wells without antigen.
Each point shows the aOD value for a single individual. Horizontal bars show medians. Differences between two time points at a single site were
tested using the Wilcoxon signed-rank test. p-values are indicated.
doi:10.1371/journal.pone.0029107.g004
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Camargue [36,41]. Although few entomological data are available
for Marseille, the anthropophilic Cx. p. molestus form is very likely
to occur there, which could represent an explanation for the
pertinent IgG increase observed during the warm season.
Nevertheless, continuous exposure or an insufficiently long period
of non-exposure to Cx. pipiens bites throughout the year could limit
the IgG baseline feedback, potentially explaining the moderate
seasonal variations of IgG that have been observed [49,50].
Collectively, these data showed that IgG antibody responses
against AecSGE and CxpSGE evolved differently according to site
and season, suggesting a specificity of the serological response
against AecSGE.
Cross-reactivity was evaluated using correlation tests between
the IgG levels against AecSGE and CxpSGE at the exposure peak.
Differences were detected in the results according to the location.
For Camargue and Marseille, the absence of a significant
correlation between the IgG levels against AecSGE and CxpSGE
corresponded to the low antigen cross-reactivity between these two
species, which belong to different genera. Conversely, for Fos-sur-
mer, a significant positive correlation was detected between these
two species. Because both species are present at this site, the
correlation could be due more to dual exposure to Ae. caspius and
Cx. pipiens than to antigen cross-reactivity. Thus, our results
support a genus-specific IgG response.
It is of note that the IgG response heterogeneity (i.e., between
individuals from the same area) observed for Cx. pipiens and, to a
lesser extent, for Ae. caspius might reflect heterogeneous exposure to
mosquito bites due to individual behaviours (e.g., outdoor/indoor
activities, use of mosquito nets or repellents). Additionally, these
two mosquito species exhibit distinct circadian biting activities (e.g.,
clearly diurnal and nocturnal biting activities are observed for Ae.
caspius and Cx. pipiens mosquitoes, respectively) [36], which could
further increase this inter-individual heterogeneity.
Finally, intra-genus specificity was estimated using SGE from
two Aedes species that were not endemic at the three sites during
the time of the study. The very low IgG levels observed against
AealSGE and AeaeSGE, independent of the site and timing,
indicated that the IgG responses to AecSGE were specific at the
species level. Nevertheless, the significant correlation coefficients
obtained when the levels of IgG against mosquitoes from the Aedes
genus were compared suggest cross-reactivity. These correlations
were not attributed to dual exposure (because these mosquitoes
were not present in the study area), but to the presence of shared
salivary antigens between different Aedes species [51].
Collectively, these data showed that the IgG antibody response
against AecSGE may be related to seasonal and geographical
variations in Ae. caspius density. The pertinent increase and
transient IgG response at the peak of exposure appears to be
species-specific, and these results strongly suggest that human
antibody responses may be used to assess the individual level of
exposure to mosquito bites. Nevertheless, other parameters should
be considered, including historical individual exposure, which
could influence the baseline IgG level. Further studies are needed
to characterise specific AecSG antigens, for instance, using an
immunoproteomic approach, as described previously [52–54].
This step of identifying the antigenic protein repertoire is
necessary to determine the diversity and specificity of this
repertoire. Salivary proteins of different arthropod species can
share sequence similarities [55] and cross-reacting antigens
[56,57], resulting in the need to select species-specific antigens.
Recombinant forms of selected salivary gland antigen candidates
could be used for the development of a more sensitive and specific
immunological test to accurately assess individual exposure to
mosquito bites. Thus, specific immune responses against mosquito
saliva antigens could be used in control and surveillance programs
to assess the efficiency of anti-mosquito strategies, to estimate
exposure levels and to identify new infestation areas. This strategy
could be extended to other mosquito species that are involved in
the transmission of infectious diseases and could represent a tool
for estimating the risk of vector-borne disease transmission.
Collectively, these data confirm that human antibody responses
Table 1. Correlation of IgG responses between mosquito species.
Ae. caspius Ae. albopictus Ae. aegypti Cx. pipiens
Camargue site
Ae. caspius 1
Ae. albopictus 0.4245 (p=0.0046)1
Ae. aegypti 0.4526 (p=0.0023) 0.6187 (p,0.0001)1
Cx. pipiens 0.3168 (p=0.0385) 0.3015 (p=0.0494) 0.2585 (p=0.0942) 1
Fos-sur-mer site
Ae. caspius 1
Ae. albopictus 0.5212 (p=0.0004)1
Ae. aegypti 0.5529 (p=0.0004) 0.6529 (p,0.0001)1
Cx. pipiens 0.4300 (p=0.0079) 0.0842 (p=0.6204) 0.2162 (p=0.1987) 1
Marseille site
Ae. caspius 1
Ae. albopictus 0.4648 (p=0.0029)1
Ae. aegypti 0.4642 (p=0.0029) 0.4796 (p=0.0020)1
Cx. pipiens 0.1978 (p=0.2274) 0.2513 (p=0.1227) 0.0799 (p=0.6289) 1
Spearman’s rank correlation coefficient (rho) and p-value between IgG responses against the salivary gland extracts of each pair of mosquito species in September 2007
(T2) (i.e., at the peak of Ae. caspius density) are listed. Significant correlations (0.05/6=0.0083, i.e., according to the Bonferroni correction for multiple testing) are
indicated in bold in brackets.
doi:10.1371/journal.pone.0029107.t001
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Materials and Methods
Ethics statement
All participants gave their written informed consent to
participate in the study, and the Marseille-2 Ethical Committee
approved the protocol (Nu2006-A00581-50). Mosquito larval
sampling was carried out in non-privately owned areas and non-
protected areas outside the boundaries of the regional nature park
of Camargue. The field study did not involve endangered or
protected species. No specific permissions were required for the
described field studies.
Study sites
The study was conducted in the Provence-Alpes-Co ˆte d’Azur
(PACA) area in southeastern France. Three study sites in PACA
were chosen: (i) Camargue, a large wetland area of 150,000
hectares [35] located inside the Rhone River delta, principally
covered with pools of water, marshes and irrigated fields, where
the human population is distributed between towns, hamlets and
isolated houses [58,59]; (ii) Fos-sur-mer, a town with 14,000
inhabitants (population density, 151 inhabitants/km
2) with a
mixed residential and agricultural landscape, located approxi-
mately 15 km from the border of the Camargue area; and (iii) the
city of Marseille, a dry, an urban area with approximately 852 400
inhabitants and located approximately 30 km from Fos-sur-mer
(Figure 1).
Studied population
Volunteers were recruited from Camargue (n=41, 54% male,
mean age 6 SD: 45.7611.3, Caucasian), Fos-sur-mer (n=26,
42% male, mean age6 SD: 51.5611, Caucasian) and Marseille
(n=38, 47% male, mean age6 SD: 40.3612.2, Caucasian). For
each individual, blood samples were collected by venous puncture
at three different time points: February 2007, September 2007 and
January 2008. Sera were obtained through centrifugation of the
blood samples and were stored at 220uC. Eligible participants
were individuals who did not travel to countries or areas that are
endemic for Ae. aegypti and Ae. albopictus mosquitoes in the six
months prior to and during the study [60–62].
Mosquitoes and salivary gland extraction
Adult female Ae. caspius, Cx pipiens, Ae. aegytpi and Ae. albopictus
mosquitoes were used in this study. Ae. caspius and Cx. pipiens
species were collected at the larval stage in the field in Camargue
from August to September 2009, and the mosquitoes were reared
in an insectarium. The Ae. albopictus mosquito colony came from
the Alpes-Maritimes area and was bred in a laboratory at the
Entente Interde ´partementale pour la De ´moustication (EID)
Me ´diterrane ´e (Cagnes-sur-Mer). Ae. aegypti mosquitoes came from
the Bora-Bora reference colony, which was bred in a laboratory at
the Institut de Recherche pour le De ´veloppement (Montpellier).
All of these mosquitoes were maintained under identical standard
conditions of 26uC and 60% humidity. All mosquitoes consumed
no blood meals and were maintained on a diet of a 10% syrup
solution. Salivary glands from 5- to 8-day old adult female
mosquitoes were dissected on ice in phosphate-buffered saline
(PBS) under a stereomicroscope. The salivary glands were pooled
by species in a microcentrifuge tube and were then stored frozen at
220uC until needed. At that time, the salivary glands were
disrupted by ultrasonication (Vibracell 72412, Bioblock Scientific,
Illkirch, France) for 5 min on ice at maximum amplitude. Salivary
gland homogenates were then centrifuged for 15 min at 16,1006g
[63] and the protein concentration of the supernatant was
determined in duplicate by the Lowry method (DC Protein assay
Kit, Bio-Rad) according to the manufacturer’s instructions.
Salivary gland proteins were then suspended in 0.1 M (pH 9.6)
bicarbonate buffer to obtain a protein concentration of 1 mg/mL.
ELISA
The sera were tested by ELISA for the presence of IgG
antibodies that bind to salivary gland proteins. To optimise the
working conditions of the ELISA tests, a checkerboard titration
was performed to establish salivary gland protein extracts and
serum conditions. Based on the results of this procedure, Maxisorp
Microtiter Immunoplates (Nunc, Denmark) were coated with
2 mg/ml (50 ml/well) of either Ae. caspius, Cx. pipiens, Ae. albopictus or
Ae. aegypti salivary gland extracts diluted in 0.1 M bicarbonate
buffer (pH 9.6) overnight at 4uC. Three washes were performed
with 250 mL of PBS (pH 7.4, Sigma Co., USA) plus 0.05%
Tween-20 (Sigma Co., USA) between each incubation. The plates
were blocked for 2 h at 37uC with 200 mL of blocking solution
buffer consisting of PBS, 0.05% Tween and 5% skimmed milk
(Beckton, Dickinson Bioscience, USA). Serum diluted 1:50 in
blocking buffer was added (50 ml/well) to the plates, and they were
incubated at 37uC for 1 h [64]. Subsequently, 50 ml of horse
radish peroxidase (HRP)-conjugated rabbit anti-human IgG
(1:10,000, Invitrogen, Rockville, USA) diluted in the blocking
buffer were added, followed by incubation for 1 h at 37uC.
Enzyme activity was detected by incubation with 50 mlo f
tetramethylbenzidine substrate (KPL, USA) for 10 min at room
temperature. The reaction was stopped using 50 mlo f1 M
H2SO4. The optical density (OD) at 450 nm was determined with
a microplate reader (Versa MaxH Turnable Multiplate Reader,
Molecular Devices, UK). Each serum sample was tested in
duplicate and in control wells without salivary gland extracts. To
improve the consistency of the results, sera from different study
sites were randomly arranged on each plate, and the samples
collected at different time points for each individual were tested on
the same plate. A pool of 5 sera collected in September 2007 from
individuals living in Camargue (selected based on ELISA
optimisation tests) was used as a positive control on all plates
coated with salivary gland extracts from Ae. caspius and Cx. Pipiens.
A pool of 5 sera from individuals living in inter-tropical areas,
kindly provided by Dr. F. Remoue ´, was used as a positive control
against salivary gland extracts from Ae. aegypti [25] and Ae.
albopictus. Only plates presenting inter-assay variations in absor-
bance values of positive controls lower than 20% were included in
the analysis. The levels of IgG antibodies were expressed as the
adjusted OD (aOD), which was calculated for each serum sample
as the mean OD value for wells with salivary gland extracts minus
the OD value of the control wells, i.e., without salivary gland
extracts. Individual variations in IgG antibody responses were
assessed according to the OD differences (DOD) between pairs of
sera collected throughout the year. To consider pertinent DOD
between pairs of sera, an arbitrary threshold of 0.1 DOD was
defined [65]. The mean aOD at the three time points for
individuals not exposed to Ae. caspius living in Marseille plus 3
standard deviations was used as the cut-off value for seropositivity.
Statistical analyses
After verifying that the values in each group did not assume a
Gaussian distribution, the Kruskal-Wallis, Mann-Whitney and
Wilcoxon matched-pairs signed-rank tests and Spearman’s rank
correlation coefficient were computed when appropriate with
STATA version 9.0 (Stata-Corp, USA). The frequencies were
Mosquito Saliva: Immunological Markers of Exposure
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significant at p,0.05. However, for multiple tests, a Bonferroni
correction was applied and p-value significance was then indicated.
Supporting Information
Table S1 Statistical analysis of spatial and temporal
variations in IgG responses. The Kruskal-Wallis tests were
used to compare the antibody levels between more than two
independent groups (geographical comparisons). Wilcoxon
matched-pairs signed-rank tests were used to compare paired sera
between two time points. All significant differences (p,0.05) are
indicated in bold. SD: standard deviation, aOD: adjusted optical
density, CI: confident interval, T1: February 07, T2: September
07, T3: January 08.
(DOC)
Table S2 Adult mosquitoes captured at each site in July
2007 using carbon dioxide dry ice traps. Carbon dioxide
traps were hung in 5 locations in each study site during 24 hrs.
Mosquitoes were identified using morphological characteristics
and identification keys. The mean number of mosquitoes sampled
in each site was calculated using the results of the five traps. The
proportion of each mosquito genus/species per site is indicated
into brackets.
(DOC)
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